Matrix Trust Co Sells 3,651 Shares of The Allstate Co. (NYSE:ALL)

Matrix Trust Co trimmed its position in shares of The Allstate Co. (NYSE:ALL - Free Report) by 26.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,939 shares of the insurance provider's stock after selling 3,651 shares during the quarter. Matrix Trust Co's holdings in Allstate were worth $1,885,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of ALL. Dimensional Fund Advisors LP grew its holdings in Allstate by 3.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider's stock worth $229,545,000 after acquiring an additional 47,038 shares during the last quarter. Hsbc Holdings PLC grew its stake in shares of Allstate by 3.3% during the second quarter. Hsbc Holdings PLC now owns 1,007,953 shares of the insurance provider's stock valued at $160,948,000 after purchasing an additional 31,789 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its holdings in shares of Allstate by 1.0% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 818,489 shares of the insurance provider's stock valued at $130,680,000 after purchasing an additional 8,454 shares in the last quarter. AQR Capital Management LLC raised its position in Allstate by 181.6% in the 2nd quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider's stock worth $114,955,000 after purchasing an additional 464,337 shares during the last quarter. Finally, Russell Investments Group Ltd. lifted its holdings in Allstate by 11.8% during the 1st quarter. Russell Investments Group Ltd. now owns 716,757 shares of the insurance provider's stock worth $123,574,000 after buying an additional 75,698 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company's stock.

Allstate Stock Up 0.4 %

Shares of NYSE:ALL traded up $0.75 during trading on Thursday, hitting $185.66. 1,271,560 shares of the company's stock traded hands, compared to its average volume of 1,548,405. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49. The company has a 50-day moving average price of $183.88 and a 200-day moving average price of $172.80. The Allstate Co. has a 52 week low of $113.04 and a 52 week high of $193.97. The company has a market cap of $49.00 billion, a price-to-earnings ratio of 40.97, a price-to-earnings-growth ratio of 1.81 and a beta of 0.48.

Allstate (NYSE:ALL - Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $1.28. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The firm had revenue of $15.71 billion for the quarter, compared to analyst estimates of $14.04 billion. During the same quarter in the previous year, the firm posted ($4.42) earnings per share. The business's revenue was up 12.4% on a year-over-year basis. As a group, research analysts forecast that The Allstate Co. will post 15.2 EPS for the current fiscal year.

Allstate Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Shareholders of record on Friday, August 30th were given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 1.98%. The ex-dividend date of this dividend was Friday, August 30th. Allstate's dividend payout ratio (DPR) is currently 81.24%.

Insider Buying and Selling at Allstate

In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the business's stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares of the company's stock, valued at $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the sale, the executive vice president now owns 19,163 shares of the company's stock, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider John E. Dugenske sold 36,367 shares of the stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 238,305 shares of company stock worth $43,082,657 over the last quarter. 1.80% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on ALL. The Goldman Sachs Group boosted their target price on Allstate from $199.00 to $204.00 and gave the stock a "buy" rating in a research report on Thursday, August 15th. Roth Mkm restated a "buy" rating and set a $200.00 target price on shares of Allstate in a research report on Wednesday, August 14th. Barclays assumed coverage on shares of Allstate in a research report on Wednesday, September 4th. They set an "underweight" rating and a $175.00 price target for the company. Wells Fargo & Company cut their price objective on shares of Allstate from $177.00 to $175.00 and set an "equal weight" rating on the stock in a report on Friday, August 16th. Finally, Piper Sandler lifted their target price on shares of Allstate from $188.00 to $196.00 and gave the stock an "overweight" rating in a report on Friday, August 16th. One research analyst has rated the stock with a sell rating, two have given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Allstate presently has a consensus rating of "Moderate Buy" and a consensus price target of $199.24.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.